IBS
EnteroBiotix begins phase 2 trial of IBS treatment
April 3, 2024Research and Development EnteroBiotix, Gastrointestinal tract, IBS, irritable bowel syndrome
EnteroBiotix has announced that it has dosed the first patient in its multi-centre, randomised, double-blind, placebo controlled clinical trial, which …
Janssen’s ulcerative colitis medicine not recommended by NICE for use in adults
January 21, 2020Manufacturing and Production IBS, Irrated Bowels, NHS, NICE, bowel, ulcerative colitis
NICE has published draft guidance which does not recommend Stelara (ustekinumab) for treating moderately to severely active ulcerative colitis in …
Bausch Health buy bankrupt Synergy Pharmaceuticals for $200m
December 13, 2018Business Services GI, IBS, basuch, cnstipation, synergy pharma
Bankrupt drug developer Synergy Pharmaceuticals has announced that the company is to be acquired by Canadian speciality pharma firm Bausch …
Immune system exhaustion associated with irritable bowel syndrome
June 21, 2017Research and Development IBS, irritable bowel syndrome, t cells
Researchers from the University of Adelaide have linked a specific type of irritable bowel syndrome with the exhaustion of the …
Allergan acquires rights to pioneering IBS treatment from Almirall
October 29, 2015Medical Communications, Sales and Marketing Allergan, Constella, IBS, linaclotide
Allergan and its commercialisation partner Ironwood Pharmaceuticals have announced that Allergan has acquired the rights to Constella.The companies have acquired …
Actavis and Valeant see FDA approval for IBS drugs
May 28, 2015Sales and Marketing Actavis, FDA, IBS, Valeant, brett wells
Both Actavis and Valeant have been shown the green light for their respective irritable bowel syndrome (IBS) treatments from the …
AstraZeneca and Ironwood announce $150 million China pact
October 25, 2012Research and Development, Sales and Marketing AstraZeneca, China, IBS, Ironwood
AstraZeneca has signed a deal with Ironwood to co-develop and co-market Ironwood’s irritable bowel syndrome treatment in China. In August …
Positive results for irritable bowel syndrome drug
September 14, 2010Research and Development Almirall, IBS, linaclotide
A new treatment for patients with irritable bowel syndrome with constipation has produced promising results in a phase III trial. …
